Dr. David Liew reviews abstract OP0124, "Effects of Nintedanib in patients with Progressive Fibrosing Interstitial Lung Disease Associated with Rheumatoid Arthritis (RA-ILD) in the INBUILD Trial", presented at the virtual EULAR 2021 meeting.
ADD THE FIRST COMMENT
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.